A study published in Aging Cell has identified immune resilience as a key driver of salutogenesis—the active process of ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

Our immune system is a complex network of organs, cells, and proteins that defend our bodies against pathogens such as ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

As we age, maintaining a strong immune system becomes more difficult than ever. Our bodies naturally change, and one of the most significant shifts is in our immune response. With age, the immune ...

Key Takeaways Immunotherapy is as effective in seniors as in younger peopleSeniors’ immune systems are weaker, and thus less ...

"Right now, we give immune checkpoint inhibitors to patients in the same way without major consideration about how their age may influence how the immune system may recognize cancer cells," he says.

The findings suggest that lipid metabolism may play a central role in maintaining a healthy immune system as we age. The researchers analyzed gene and protein expression, along with lipid profiles ...

As we age, our immune system weakens, producing fewer cells that fight infection and aid recovery. While the exact cause has remained unclear, a new study in GeroScience may offer answers.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...